Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 15 June, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 504067 | NSE: ZENSARTECH

Zensar Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 14, 2025, 9:52 am

Market Cap 19,703 Cr.
Current Price 867
High / Low 985/536
Stock P/E30.3
Book Value 179
Dividend Yield1.04 %
ROCE22.0 %
ROE17.0 %
Face Value 2.00
PEG Ratio1.83

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Zensar Technologies Ltd

Competitors of Zensar Technologies Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
IDream Film Infrastructure Company Ltd 1.98 Cr. 132 132/89.3 3030.00 %%% 10.0
I Power Solutions India Ltd 8.17 Cr. 18.4 18.4/11.9 7.820.00 %11.2 %16.4 % 10.0
Hypersoft Technologies Ltd 9.06 Cr. 21.3 21.3/13.843.1 5.690.00 %20.6 %9.07 % 10.0
Zensar Technologies Ltd 19,703 Cr. 867 985/53630.3 1791.04 %22.0 %17.0 % 2.00
Sonata Software Ltd 11,534 Cr. 411 764/28627.2 60.81.92 %29.1 %27.3 % 1.00
Industry Average137,773.80 Cr989.9452.24167.190.75%21.15%19.41%6.90

All Competitor Stocks of Zensar Technologies Ltd

Quarterly Result

MetricMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Sales 1,1541,2031,2351,1981,2131,2271,2411,2041,2301,2881,3081,3261,359
Expenses 9901,0671,1291,0631,0379971,0109961,0271,0921,1071,1191,146
Operating Profit 164136105135176230231208203196201207212
OPM % 14%11%9%11%14%19%19%17%17%15%15%16%16%
Other Income 72212826272836425242413146
Interest 9688666634445
Depreciation 48494950354237312425302424
Profit before tax 18010277104162210225212229210208210230
Tax % 27%26%26%26%26%26%23%24%24%25%25%24%23%
Net Profit 131755776119156174162173158156160176
EPS in Rs 5.743.322.513.385.276.907.687.147.656.976.867.047.77

Last Updated: May 25, 2025, 6:26 pm

Below is a detailed analysis of the quarterly data for Zensar Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Sales, as of Mar 2025, the value is 1,359.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,326.00 Cr. (Dec 2024) to 1,359.00 Cr., marking an increase of 33.00 Cr..
  • For Expenses, as of Mar 2025, the value is 1,146.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,119.00 Cr. (Dec 2024) to 1,146.00 Cr., marking an increase of 27.00 Cr..
  • For Operating Profit, as of Mar 2025, the value is 212.00 Cr.. The value appears strong and on an upward trend. It has increased from 207.00 Cr. (Dec 2024) to 212.00 Cr., marking an increase of 5.00 Cr..
  • For OPM %, as of Mar 2025, the value is 16.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 16.00%.
  • For Other Income, as of Mar 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Dec 2024) to 46.00 Cr., marking an increase of 15.00 Cr..
  • For Interest, as of Mar 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Dec 2024) to 5.00 Cr., marking an increase of 1.00 Cr..
  • For Depreciation, as of Mar 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 24.00 Cr..
  • For Profit before tax, as of Mar 2025, the value is 230.00 Cr.. The value appears strong and on an upward trend. It has increased from 210.00 Cr. (Dec 2024) to 230.00 Cr., marking an increase of 20.00 Cr..
  • For Tax %, as of Mar 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Dec 2024) to 23.00%, marking a decrease of 1.00%.
  • For Net Profit, as of Mar 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 160.00 Cr. (Dec 2024) to 176.00 Cr., marking an increase of 16.00 Cr..
  • For EPS in Rs, as of Mar 2025, the value is 7.77. The value appears strong and on an upward trend. It has increased from 7.04 (Dec 2024) to 7.77, marking an increase of 0.73.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:45 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Sales 2,3352,6562,9523,0563,1083,9664,1823,7814,2444,8484,9025,281
Expenses 1,9772,2642,5132,6742,7433,4873,6753,0973,5874,2964,0304,464
Operating Profit 358392439382365479507685656552872817
OPM % 15%15%15%12%12%12%12%18%15%11%18%15%
Other Income 30275424749388-24138103159160
Interest 10111192337615435282117
Depreciation 384265496589159175185183134102
Profit before tax 340366417349352445376433574444876858
Tax % 30%28%30%32%30%28%28%29%27%26%24%24%
Net Profit 238265292238246319272307422328665650
EPS in Rs 10.8611.9412.9710.4710.7413.9311.6913.3018.4014.4729.3428.61
Dividend Payout % 18%18%18%23%22%20%24%27%27%35%31%45%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)11.34%10.19%-18.49%3.36%29.67%-14.73%12.87%37.46%-22.27%102.74%-2.26%
Change in YoY Net Profit Growth (%)0.00%-1.16%-28.68%21.85%26.31%-44.41%27.60%24.59%-59.73%125.02%-105.00%

Zensar Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:5%
3 Years:8%
TTM:8%
Compounded Profit Growth
10 Years:10%
5 Years:21%
3 Years:16%
TTM:0%
Stock Price CAGR
10 Years:21%
5 Years:45%
3 Years:48%
1 Year:25%
Return on Equity
10 Years:16%
5 Years:16%
3 Years:16%
Last Year:17%

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:25 pm

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 444445454545454545454545
Reserves 9021,1131,2201,4271,6241,8972,0452,2972,6422,9313,5174,024
Borrowings 1701761491349300332350335273186125
Other Liabilities 3704024555006188471,174742817872899978
Total Liabilities 1,4861,7341,8692,1062,2963,0903,5963,4333,8404,1214,6485,173
Fixed Assets 4225473864475929501,3231,1331,2541,1741,0341,170
CWIP 21236121101051
Investments 149941342432751152785173248991,4081,714
Other Assets 9141,0921,3471,4131,4242,0131,9831,7832,2602,0492,2002,288
Total Assets 1,4861,7341,8692,1062,2963,0903,5963,4333,8404,1214,6485,173

Below is a detailed analysis of the balance sheet data for Zensar Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 45.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 45.00 Cr..
  • For Reserves, as of Mar 2025, the value is 4,024.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,517.00 Cr. (Mar 2024) to 4,024.00 Cr., marking an increase of 507.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 125.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 186.00 Cr. (Mar 2024) to 125.00 Cr., marking a decrease of 61.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 978.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 899.00 Cr. (Mar 2024) to 978.00 Cr., marking an increase of 79.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 5,173.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,648.00 Cr. (Mar 2024) to 5,173.00 Cr., marking an increase of 525.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 1,170.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,034.00 Cr. (Mar 2024) to 1,170.00 Cr., marking an increase of 136.00 Cr..
  • For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 4.00 Cr..
  • For Investments, as of Mar 2025, the value is 1,714.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,408.00 Cr. (Mar 2024) to 1,714.00 Cr., marking an increase of 306.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 2,288.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,200.00 Cr. (Mar 2024) to 2,288.00 Cr., marking an increase of 88.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 5,173.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,648.00 Cr. (Mar 2024) to 5,173.00 Cr., marking an increase of 525.00 Cr..

Notably, the Reserves (4,024.00 Cr.) exceed the Borrowings (125.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +209321255304206156686858336714642565
Cash from Investing Activity +-128-182-41-204-142-229-315-5303-527-476-488
Cash from Financing Activity +-77-87-129-50-204201-197-467-183-219-197-264
Net Cash Flow4518550-140128175-139156-31-31-187

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow188.00216.00290.00248.00356.00179.00175.00335.00321.00279.00686.00692.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days566267647581585769555555
Inventory Days272266304
Days Payable300283400
Cash Conversion Cycle2845-29647581585769555555
Working Capital Days4755746570714028442732120
ROCE %34%30%31%24%23%23%18%21%21%15%25%22%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Promoters49.16%49.16%49.15%49.21%49.21%49.20%49.20%49.18%49.17%49.14%49.10%49.07%
FIIs15.95%9.18%10.75%10.53%12.59%16.66%17.12%16.53%15.74%14.84%15.06%14.98%
DIIs13.91%12.52%11.45%15.77%17.30%16.55%16.45%17.53%19.04%19.05%19.83%19.89%
Public20.99%29.13%28.63%24.48%20.89%17.59%17.23%16.77%16.06%16.98%16.01%16.06%
No. of Shareholders1,86,5592,22,9742,24,5112,11,7541,97,8262,17,6992,25,6572,16,9352,01,7772,17,2182,03,5922,25,502

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Hybrid Equity Fund - Regular Plan 5,550,731 1.67 389.025,750,7312025-05-25 10:25:42-3.48%
HDFC Small Cap Fund - Regular Plan 4,695,030 1.09 329.05N/AN/AN/A
Franklin India Smaller Companies Fund 3,062,700 1.79 214.652,532,0332025-05-25 10:25:4220.96%
HSBC Value Fund 2,546,500 1.42 178.473,524,0002025-05-25 10:25:42-27.74%
Nippon India Small Cap Fund 2,496,604 0.32 174.974,039,1762025-05-25 10:25:42-38.19%
ICICI Prudential Technology Fund 1,570,526 0.86 110.073,334,4922025-05-25 10:25:42-52.9%
HDFC Childrens Gift Fund - Regular Plan 1,323,821 0.97 92.781,423,8212025-05-25 10:25:42-7.02%
Nippon India Flexi Cap Fund 989,733 0.84 69.37989,7332025-04-22 17:25:150%
UTI Small Cap Fund 908,688 1.54 63.69N/AN/AN/A
Edelweiss Small Cap Fund 811,960 1.4 56.91N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 28.6529.3614.4718.4313.31
Diluted EPS (Rs.) 28.4329.1314.4018.2713.18
Cash EPS (Rs.) 33.1135.2722.5426.8421.35
Book Value[Excl.RevalReserv]/Share (Rs.) 179.28157.26131.40118.89105.10
Book Value[Incl.RevalReserv]/Share (Rs.) 179.28157.26131.40118.89105.10
Revenue From Operations / Share (Rs.) 232.63216.42214.05187.78167.61
PBDIT / Share (Rs.) 43.0445.5028.9235.1431.48
PBIT / Share (Rs.) 38.5539.5920.8426.9623.74
PBT / Share (Rs.) 37.7838.6719.6125.4019.19
Net Profit / Share (Rs.) 28.6329.3614.4618.6613.61
NP After MI And SOA / Share (Rs.) 28.6329.3614.4618.4213.30
PBDIT Margin (%) 18.4921.0213.5118.7118.78
PBIT Margin (%) 16.5718.299.7314.3514.16
PBT Margin (%) 16.2417.869.1613.5211.44
Net Profit Margin (%) 12.3013.566.759.938.11
NP After MI And SOA Margin (%) 12.3013.566.759.807.93
Return on Networth / Equity (%) 15.9618.6611.0015.4912.80
Return on Capital Employeed (%) 20.3923.6314.4620.0319.87
Return On Assets (%) 12.5614.307.9410.758.73
Long Term Debt / Equity (X) 0.000.000.000.080.00
Total Debt / Equity (X) 0.000.000.000.080.00
Asset Turnover Ratio (%) 1.081.121.210.540.46
Current Ratio (X) 3.763.042.702.732.70
Quick Ratio (X) 3.763.042.702.732.70
Dividend Payout Ratio (NP) (%) 0.0018.7334.5521.169.01
Dividend Payout Ratio (CP) (%) 0.0015.5922.1614.655.69
Earning Retention Ratio (%) 0.0081.2765.4578.8490.99
Cash Earning Retention Ratio (%) 0.0084.4177.8485.3594.31
Interest Coverage Ratio (X) 56.4749.3123.4822.5013.27
Interest Coverage Ratio (Post Tax) (X) 38.5632.8212.7412.957.65
Enterprise Value (Cr.) 15171.3712988.215476.977684.405517.20
EV / Net Operating Revenue (X) 2.872.651.131.811.46
EV / EBITDA (X) 15.5312.608.369.687.77
MarketCap / Net Operating Revenue (X) 3.012.801.281.961.64
Retention Ratios (%) 0.0081.2665.4478.8390.98
Price / BV (X) 3.913.852.083.092.64
Price / Net Operating Revenue (X) 3.012.801.281.961.64
EarningsYield 0.040.040.050.050.04

After reviewing the key financial ratios for Zensar Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 28.65. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.65, marking a decrease of 0.71.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 28.43. This value is within the healthy range. It has decreased from 29.13 (Mar 24) to 28.43, marking a decrease of 0.70.
  • For Cash EPS (Rs.), as of Mar 25, the value is 33.11. This value is within the healthy range. It has decreased from 35.27 (Mar 24) to 33.11, marking a decrease of 2.16.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.28. It has increased from 157.26 (Mar 24) to 179.28, marking an increase of 22.02.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.28. It has increased from 157.26 (Mar 24) to 179.28, marking an increase of 22.02.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 232.63. It has increased from 216.42 (Mar 24) to 232.63, marking an increase of 16.21.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 43.04. This value is within the healthy range. It has decreased from 45.50 (Mar 24) to 43.04, marking a decrease of 2.46.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 38.55. This value is within the healthy range. It has decreased from 39.59 (Mar 24) to 38.55, marking a decrease of 1.04.
  • For PBT / Share (Rs.), as of Mar 25, the value is 37.78. This value is within the healthy range. It has decreased from 38.67 (Mar 24) to 37.78, marking a decrease of 0.89.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 28.63. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.63, marking a decrease of 0.73.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 28.63. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.63, marking a decrease of 0.73.
  • For PBDIT Margin (%), as of Mar 25, the value is 18.49. This value is within the healthy range. It has decreased from 21.02 (Mar 24) to 18.49, marking a decrease of 2.53.
  • For PBIT Margin (%), as of Mar 25, the value is 16.57. This value is within the healthy range. It has decreased from 18.29 (Mar 24) to 16.57, marking a decrease of 1.72.
  • For PBT Margin (%), as of Mar 25, the value is 16.24. This value is within the healthy range. It has decreased from 17.86 (Mar 24) to 16.24, marking a decrease of 1.62.
  • For Net Profit Margin (%), as of Mar 25, the value is 12.30. This value exceeds the healthy maximum of 10. It has decreased from 13.56 (Mar 24) to 12.30, marking a decrease of 1.26.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.30. This value is within the healthy range. It has decreased from 13.56 (Mar 24) to 12.30, marking a decrease of 1.26.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 15.96. This value is within the healthy range. It has decreased from 18.66 (Mar 24) to 15.96, marking a decrease of 2.70.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has decreased from 23.63 (Mar 24) to 20.39, marking a decrease of 3.24.
  • For Return On Assets (%), as of Mar 25, the value is 12.56. This value is within the healthy range. It has decreased from 14.30 (Mar 24) to 12.56, marking a decrease of 1.74.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.08. It has decreased from 1.12 (Mar 24) to 1.08, marking a decrease of 0.04.
  • For Current Ratio (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 3. It has increased from 3.04 (Mar 24) to 3.76, marking an increase of 0.72.
  • For Quick Ratio (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 2. It has increased from 3.04 (Mar 24) to 3.76, marking an increase of 0.72.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 18.73 (Mar 24) to 0.00, marking a decrease of 18.73.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 15.59 (Mar 24) to 0.00, marking a decrease of 15.59.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 81.27 (Mar 24) to 0.00, marking a decrease of 81.27.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 84.41 (Mar 24) to 0.00, marking a decrease of 84.41.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 56.47. This value is within the healthy range. It has increased from 49.31 (Mar 24) to 56.47, marking an increase of 7.16.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 38.56. This value is within the healthy range. It has increased from 32.82 (Mar 24) to 38.56, marking an increase of 5.74.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 15,171.37. It has increased from 12,988.21 (Mar 24) to 15,171.37, marking an increase of 2,183.16.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 2.87, marking an increase of 0.22.
  • For EV / EBITDA (X), as of Mar 25, the value is 15.53. This value exceeds the healthy maximum of 15. It has increased from 12.60 (Mar 24) to 15.53, marking an increase of 2.93.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 24) to 3.01, marking an increase of 0.21.
  • For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 81.26 (Mar 24) to 0.00, marking a decrease of 81.26.
  • For Price / BV (X), as of Mar 25, the value is 3.91. This value exceeds the healthy maximum of 3. It has increased from 3.85 (Mar 24) to 3.91, marking an increase of 0.06.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 24) to 3.01, marking an increase of 0.21.
  • For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Zensar Technologies Ltd as of June 15, 2025 is: 745.29

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 15, 2025, Zensar Technologies Ltd is Overvalued by 14.04% compared to the current share price 867.00

Intrinsic Value of Zensar Technologies Ltd as of June 15, 2025 is: 868.68

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 15, 2025, Zensar Technologies Ltd is Undervalued by 0.19% compared to the current share price 867.00

Last 5 Year EPS CAGR: 16.56%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 23.92%, which is a positive sign.
  2. The company has higher reserves (2,136.58 cr) compared to borrowings (211.58 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (3.25 cr) and profit (485.83 cr) over the years.
  1. The stock has a high average Working Capital Days of 56.08, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 51.08, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zensar Technologies Ltd:
    1. Net Profit Margin: 12.3%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 20.39% (Industry Average ROCE: 21.15%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 15.96% (Industry Average ROE: 19.41%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 38.56
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 3.76
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 30.3 (Industry average Stock P/E: 52.24)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Zensar Technologies Ltd. is a Public Limited Listed company incorporated on 29/03/1963 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L72200PN1963PLC012621 and registration number is 012621. Currently Company is involved in the business activities of Providing software support and maintenance to the clients. Company's Total Operating Revenue is Rs. 2226.10 Cr. and Equity Capital is Rs. 45.40 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
IT Consulting & SoftwareZensar Knowledge Park, Kharadi, Plot # 4, MIDC, Pune Maharashtra 411014investor@zensar.com
http://www.zensar.com
Management
NamePosition Held
Mr. H V GoenkaChairman & Non-Exe.Director
Mr. Anant GoenkaVice Chairman & Non Exe.Dire
Mr. Manish TandonManaging Director & CEO
Mr. Ketan DalalInd. Non-Executive Director
Mr. A T VaswaniInd. Non-Executive Director
Mr. Ben DruskinInd. Non-Executive Director
Ms. Radha RajappaInd. Non-Executive Director
Mr. U B Pravin RaoInd. Non-Executive Director
Mr. Harsh MariwalaInd. Non-Executive Director

FAQ

What is the intrinsic value of Zensar Technologies Ltd?

Zensar Technologies Ltd's intrinsic value (as of 15 June 2025) is ₹745.29 — 14.04% lower the current market price of 867.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 19,703 Cr. market cap, FY2025-2026 high/low of ₹985/536, reserves of 4,024 Cr, and liabilities of 5,173 Cr.

What is the Market Cap of Zensar Technologies Ltd?

The Market Cap of Zensar Technologies Ltd is 19,703 Cr..

What is the current Stock Price of Zensar Technologies Ltd as on 15 June 2025?

The current stock price of Zensar Technologies Ltd as on 15 June 2025 is 867.

What is the High / Low of Zensar Technologies Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Zensar Technologies Ltd stocks is ₹985/536.

What is the Stock P/E of Zensar Technologies Ltd?

The Stock P/E of Zensar Technologies Ltd is 30.3.

What is the Book Value of Zensar Technologies Ltd?

The Book Value of Zensar Technologies Ltd is 179.

What is the Dividend Yield of Zensar Technologies Ltd?

The Dividend Yield of Zensar Technologies Ltd is 1.04 %.

What is the ROCE of Zensar Technologies Ltd?

The ROCE of Zensar Technologies Ltd is 22.0 %.

What is the ROE of Zensar Technologies Ltd?

The ROE of Zensar Technologies Ltd is 17.0 %.

What is the Face Value of Zensar Technologies Ltd?

The Face Value of Zensar Technologies Ltd is 2.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Zensar Technologies Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE